← Leaderboards
Michael Joseph Vido
Thomas Jefferson University
$192,753
Attributed
$192,753
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $50K · FY2016–20$100K$75K$50K$25K$0
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$192,753 · 1
By mechanism
F30$192,753 · 1
Top collaborators
No co-investigators on record.
Most similar at Thomas Jefferson University
Same institution · by research overlap
- Hushan Yang$4,413,023
- Nicole L Simone$4,293,605
- John Eisenbrey$7,634,263
- Edward Hartsough$1,866,642
- Sheera Rosenbaum$544,723
Others in their field
Top investigators on “Length”
- Lawrence Corey · Fred Hutchinson Cancer Center$200,230,827
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Richard K. Wilson · Washington University$134,449,861
- Eric S Lander · Whitehead Institute For Biomedical Res$71,530,862
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Bruce J Hillman · American College Of Radiology$58,969,992
Research focus
LengthMaintenanceBinding ProteinsArginineBindingLeadCellsCessation Of LifeBinding SitesDimerizationBraf GeneExcisionExhibitsCell LineFamilyFutureGenerationsImproved OutcomeIncidenceInhibitor/AntagonistIn VitroIn VivoKnock-DownMediating
Grant awards (5)
BRAF splice variants in RAF inhibitor resistant melanoma$7,026
F30 · FY2020 · CA · contact PI
BRAF splice variants in RAF inhibitor resistant melanoma$50,016
F30 · FY2019 · CA · contact PI
BRAF splice variants in RAF inhibitor resistant melanoma$45,713
F30 · FY2018 · CA · contact PI
BRAF splice variants in RAF inhibitor resistant melanoma$45,233
F30 · FY2017 · CA · contact PI
BRAF splice variants in RAF inhibitor resistant melanoma$44,765
F30 · FY2016 · CA · contact PI